The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper
- 1 July 1978
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 28 (7) , 734
- https://doi.org/10.1212/wnl.28.7.734
Abstract
Chronic administration of a levodopacarbidopa combination, bromocriptine, or lergotrile produced alterations of essential metal concentrations in the guinea pig caudate nucleus, frontal cortex, and cerebellar hemisphere. All long-term treatment regimens resulted in significantly increased concentrations of manganese in all brain areas, and these same regimens resulted in almost universally decreased copper concentrations. Since the long-term administration of these dopamine agonists in man results in extrapyramidal dysfunction, these observations suggest that alterations of trace metal concentrations in the brain may be related to the chronic toxicity of these dopamine agonists.This publication has 6 references indexed in Scilit:
- Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: Role of protein kinase G nitrationJournal of Cellular Physiology, 2011
- Five Years' Treatment of Parkinson's Disease with LevodopaAnnals of Internal Medicine, 1975
- Hallervorden-spatz disease?Late infantile and adult types, report of two casesActa Neuropathologica, 1968
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967
- Chronic manganese poisoningNeurology, 1967
- THE COPPER AND IRON CONTENT OF BRAIN AND LIVER IN THE NORMAL AND IN HEPATO-LENTICULAR DEGENERATIONBrain, 1948